Keith Woods
CIK: 0001996804
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 24, 2026SRRK
Scholar Rock Holding Corp
Gift(G)Direct48K shares- - May 20, 2026TCRX
TScan Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
67K shares- - Apr 16, 2026SRRK
Scholar Rock Holding Corp
Sale(S)Direct10.2K shares at avg. $49.57$507K - Feb 20, 2026NGNE
Neurogene Inc.
Award(A)DirectNon-Qualified Stock Option (right to buy)
12.1K shares- - Feb 9, 2026SRRK
Scholar Rock Holding Corp
Award(A)Direct47K shares- - Jan 13, 2026SRRK
Scholar Rock Holding Corp
Sale(S)Direct16.7K shares at avg. $42.70$715K - Jun 30, 2025TCRX
TScan Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
67K shares- - Jun 12, 2025NGNE
Neurogene Inc.
Award(A)DirectNon-Qualified Stock Option (right to buy)
12.1K shares- - Jun 9, 2025XFOR
X4 Pharmaceuticals, Inc
Award(A)Direct1.5K shares- - May 2, 2025SRRK
Scholar Rock Holding Corp
Award(A)DirectStock Option (Right to Buy)
110.1K shares- - Apr 27, 2025SRRK
Scholar Rock Holding Corp
Award(A)Direct500K shares- - Apr 27, 2025SRRK
Scholar Rock Holding Corp
Award(A)Direct100K shares- - Jun 14, 2024NGNE
Neurogene Inc.
Award(A)DirectStock Option (Right to Buy)
7.7K shares- - Jan 16, 2024NGNE
Neurogene Inc.
Award(A)DirectStock Option (Right to Buy)
15.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 |  SRRK Scholar Rock Holding Corp | Gift(G) | 48,034 | - | $0 | Direct |
| May 20, 2026 |  TCRX TScan Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 67,000 | - | - | Direct |
| Apr 16, 2026 | SRRK Scholar Rock Holding Corp | Sale(S) | 10,220 | $49.57 | $506,651 | Direct |
| Feb 20, 2026 |  NGNE Neurogene Inc. | Award(A) Non-Qualified Stock Option (right to buy) | 12,050 | - | - | Direct |
| Feb 9, 2026 | SRRK Scholar Rock Holding Corp | Award(A) | 47,021 | - | $0 | Direct |
| Jan 13, 2026 | SRRK Scholar Rock Holding Corp | Sale(S) | 16,746 | $42.70 | $715,054 | Direct |
| Jun 30, 2025 | TCRX TScan Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 67,000 | - | - | Direct |
| Jun 12, 2025 | NGNE Neurogene Inc. | Award(A) Non-Qualified Stock Option (right to buy) | 12,050 | - | - | Direct |
| Jun 9, 2025 |  XFOR X4 Pharmaceuticals, Inc | Award(A) | 1,500 | - | - | Direct |
| May 2, 2025 | SRRK Scholar Rock Holding Corp | Award(A) Stock Option (Right to Buy) | 110,067 | - | - | Direct |
| Apr 27, 2025 | SRRK Scholar Rock Holding Corp | Award(A) | 500,000 | - | - | Direct |
| Apr 27, 2025 | SRRK Scholar Rock Holding Corp | Award(A) | 100,000 | - | - | Direct |
| Jun 14, 2024 | NGNE Neurogene Inc. | Award(A) Stock Option (Right to Buy) | 7,700 | - | - | Direct |
| Jan 16, 2024 | NGNE Neurogene Inc. | Award(A) Stock Option (Right to Buy) | 15,400 | - | - | Direct |
1-14 of 14 transactions
About Woods Keith
Woods Keith (SEC CIK 0001996804) files insider reports with the SEC as Chief Operating Officer of Scholar Rock Holding Corp (SRRK), Director of Neurogene Inc. (NGNE) and Director of TScan Therapeutics, Inc. (TCRX). Signal8 also holds filings tied to 1 other company.
Signal8 holds 15 ownership filings by Woods Keith (2 Form 3, 13 Form 4), filed between Apr 29, 2025 and Sep 25, 2026. Those filings report 14 transactions, from Jan 16, 2024 to Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Woods Keith's filings is in CAMBRIDGE, MA.
Recent filings by Woods Keith
- Sep 24, 2026: Gift of SRRK shares (Form 4, code G).
- May 20, 2026: Grant or award of TCRX derivative securities (Form 4, code A).
- Apr 16, 2026: Open-market sale of SRRK shares (Form 4, code S).
- Feb 20, 2026: Grant or award of NGNE derivative securities (Form 4, code A).
- Feb 9, 2026: Grant or award of SRRK shares (Form 4, code A).
Other insiders filing for Scholar Rock Holding Corp (SRRK)
- AKKARAJU SRINIVAS, Director
- Hallal David, Chief Executive Officer
- FLIER JEFFREY S., Director
- Gilman Michael, Director
- Burow Kristina, Director
- Reed Joshua, Director